Elan reports third quarter revenues dipped 2% and net loss was at $43.6m
Oct 27th, 2010 | By Finfacts Ireland Business & Finance Portal | Category: News worldwide
Elan, the Irish pharmaceutical firm, today reported third quarter revenues of $281m, down 2% from the $287m for the same period last year. The company said it made a net loss of $43.6m for the three months to September 2010 compared to a net income of $52.3m last year.